Used in research and development of diagnostic and therapeutic agents for Alzheimer’s disease. Binds specifically to amyloid-beta peptides, enabling detection and quantification of amyloid plaques in brain tissue and biological fluids. Employed in immunoassays, immunohistochemistry, and imaging techniques to study disease progression. Supports target validation and evaluation of anti-amyloid drug candidates in preclinical models. Also utilized as a control antibody in assays assessing amyloid-beta aggregation and clearance mechanisms.